DexCom (DXCM) Tops Q2 EPS by 3c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $75.37 +0.16%
Revenue Growth %: +11.2%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +11.2%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.48, $0.03 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.12 billion.
GUIDANCE:
DexCom sees FY2025 revenue of $4.6-4.625 billion, versus the consensus of $4.611 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA clears first over-the-counter glucose monitor for children
- XORTX to voluntarily delist from TSX Venture Exchange
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
